Device Week – Episode 26
This article was originally published in The Gray Sheet
On this week's podcast, the "Gray Sheet" team talks about how to set up effective "war rooms" during an FDA inspection; compliance updates from a FDLI meeting; the latest on user-fee reauthorization negotiations; and more regulatory and business updates.
You may also be interested in...
The latest drug development news and highlights from the Pink Sheet’s US FDA Performance Tracker.
US FDA’s latest effort to provide guidance for consumers on pharmacogenomics tests underscores the challenges the agency faces in the absence of a clear regulatory framework for lab-developed tests – and with no easy mechanism to update labels for off-patent drugs.